Compare OBK & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | OPK |
|---|---|---|
| Founded | 1912 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2018 | 1995 |
| Metric | OBK | OPK |
|---|---|---|
| Price | $38.38 | $1.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $43.00 | $2.28 |
| AVG Volume (30 Days) | 143.3K | ★ 3.1M |
| Earning Date | 01-21-2026 | 10-29-2025 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | $325,588,000.00 | ★ $642,067,000.00 |
| Revenue This Year | $13.94 | N/A |
| Revenue Next Year | $6.04 | N/A |
| P/E Ratio | $20.11 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.80 | $1.11 |
| 52 Week High | $41.17 | $2.04 |
| Indicator | OBK | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 58.34 | 39.62 |
| Support Level | $38.51 | $1.29 |
| Resistance Level | $38.92 | $1.37 |
| Average True Range (ATR) | 0.76 | 0.05 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 41.74 | 10.06 |
Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.